Michael M. Abecassis - Apr 30, 2024 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role
Director
Signature
/s/ Michael M. Abecassis
Stock symbol
PMCB
Transactions as of
Apr 30, 2024
Transactions value $
$0
Form type
4
Date filed
7/17/2024, 04:58 PM
Previous filing
Nov 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMCB Stock Option (Right to Buy) Award $0 +38K $0.00 38K Apr 30, 2024 Common Stock 38K $2.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis.